Treatment Of Secondary Progressive Ms

Featured Health Expert
428_8216
EXPERT

Dirucotide: A Potential Treatment

We talk a lot about the treatment of relapsing-remitting MSM but we really want to develop more treatment options for progressive MS.

 

Dirucotide (MBP8298) is being studied in clinical trials for the treatment of secondary progressive MS (SPMS) at 68 sites with approximately 510 patients. The FDA has given fast track status because of the potential to do good for people with SPMS as it has the potential to address unmet medical needs. Fast track designation can potentially facilitate...

Read more

More information on "Treatment Of Secondary Progressive Ms"

From Our Experts

See more SharePosts »

From Our Sources

More on Multiple Sclerosis »